Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02586857
Title A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Acerta Pharma BV
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Los Angeles California 90095-1769 United States Details
Research Site Palo Alto California 94304 United States Details
Research Site Boston Massachusetts 02114 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Boston Massachusetts 2215 United States Details
Research Site New York New York 10021 United States Details
Research Site Vancouver Washington 98684 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field